NRX Pharmaceuticals NRXP Earnings Call Transcripts

NASDAQ NRXP
$2.44 +0.08 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST
1 earnings call on file for NRX Pharmaceuticals, Q1 2026. Each transcript opens in a new tab.
Latest earnings call

NRX Pharmaceuticals Q1 2026 Earnings Call

May 18, 2026 4,174 words · 18 min read
  • Jonathan JavittChief Executive Officer
  • Michael AbramsChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

NRX Pharmaceuticals Earnings Call Transcripts

Calls1
LatestMay 18, 2026
SinceQ1 2026

Fiscal 2026

All 1 NRX Pharmaceuticals transcript Register to get access to NRX Pharmaceuticals’s earnings call transcripts.